ADC Therapeutics SA (NYSE:ADCT)
The Relative Value of one ADCT stock under the Base Case scenario is 15.32 USD. Compared to the current market price of 7.89 USD, ADC Therapeutics SA is Undervalued by 49%.
Relative valuation is one of two methods of placing a monetary value on a company; the other is Discounted Cash Flow valuation method. We use a combination of these two methods to calculate the Intrinsic Value of stock as accurately as possible.